• Home
  • About
  • IMMUNEPlus
  • Research
  • Upcomming Shows
  • Careers
  • Find A Representative
  • Distributors
  • Technology
  • Contact
  • ENDOVAC Bovi Beef
  • ENDOVAC Bovi Dairy
  • ENDOVAC Porci
  • SEPTI Serum Canine
  • ENDOVAC Equi & SEPTISERUM Equine

Research

Supporting Data
Select a product to view product specific supporting data.
Case Studies
Select a product to view product specific supporting data.

Featured Research:

Protection of Ponies from Heterologous and Homologous Endotoxin challenges via Salmonella Typhimurium Bacterin-Toxoid

Twenty normal ponies were vaccinated twice with a Salmonella typhimurium bacterin-toxoid at 14-day intervals. Simultaneously, 20 normal control ponies each received two injections of dialuminum trioxide/saline placebo at 14-day intervals.

Read More »
Cross-Protection of Ponies from Sublethal Escherichia Coli Endotoxemia by Salmonella Typhimurium Antiserum

Normal ponies were passively immunized with antiserum. The antiserum contained an endotoxin-specific IgG(t) antibody titer of > 1:16000 and a total IgG antibody level of > 3000 mg/dl, which was harvested from horses hyperimmunized with a Salmonella typhimurium bacterin-toxoid.

Click to Download PDF

Short Term Effect of E. Coli Bacterin-Toxiod Vaccine on Milk Production

The purpose was to determine if immunization with an E. coli Bacterin-Toxoid J-5 Mutant in lactating cattle produced a significant change in milk production compared to saline control.

Read More »
Supplement Information for Registration in Canada

Determine the effects of vaccinations with ENDOVAC – BOVI of lactating dairy cows.

Click to Download PDF

Rethinking Coliform Vaccine Programs

Core antigen vaccine technology has been available for the prevention of coliform mastitis for over ten years.

Click to Download PDF

ENDOVAC-Bovi® with Immune Plus

What is gram-negative ENDOTOXEMIA?

Click to Download PDF

Active Immunization of Cows With Salmonella Bacterin Toxoid

Gram-negative endotoxins have been implicated in the pathogenesis of equine CHO laminitis1, bovine coliform mastitis2, and adult and neonatal septicemias.3,4,5,6 Fortuitously, the demonstration that cattle2,5,6 and horses3,4 could be protected from various Gram-negative endotoxins via anti-core-antigen antibodies offers viable possibilities for immunologically protecting animals from the deadly effects of endotoxemia.

Click to Download PDF

ENDOVAC-Bovi® in Lactating Dairy in Cows

Mastitis occurs in 10% to 12%  of all lactating cows inthe United States, with 30% to
40% of mastitis cows have inflammation due to Escherichia coli. Mastitis costs U.S. dairy
producers more than $1 billion annually.

Click to Download PDF

Effect of Re-17 Mutant Salmonella typhimurium Bacterin-Toxoid on Respiratory Disease and Production

Endotoxemias associated with bovine respiratory disease complex (BRDC) have been effectively controlled in lightweight Holstein feeder steers by Re-17 mutant Salmonella typhimurium bacterin-toxoid (ENDOVAC-Bovi® United States Department of Agriculture-licensed S. Typhimurium Bacterin-Toxoid: IMMVAC, Inc., Columbia, MO).1

Click to Download PDF

Cross-Protection of Feedlot Calves Against Pasteurella Endotoxemia

In this study, 149 lightweight feeder steers were randomly divided into three groups.  All steers were administered appropriate viral vaccines upon arrival and 10 days following arrival.

Click to Download PDF

«« Back || Next »»

Home | About | IMMUNEPlus | Research | Upcomming Shows | Careers | Find A Representative | Distributors | Technology | Contact
Products: ENDOVAC Bovi Beef | ENDOVAC Bovi Dairy | ENDOVAC Porci | SEPTI Serum Canine | ENDOVAC Equi & SEPTISERUM Equine
(c) 2010 IMMVAC All Rights Reserved.

Powered by WordPress and website design by MayeCreate Design.